share_log

Is Science Applications International (NASDAQ:SAIC) Using Too Much Debt?

Is Science Applications International (NASDAQ:SAIC) Using Too Much Debt?

science applications international (納斯達克: SAIC) 是否使用了過多債務?
Simply Wall St ·  06/04 02:41

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. Importantly, Science Applications International Corporation (NASDAQ:SAIC) does carry debt. But should shareholders be worried about its use of debt?

霍華德馬克斯說得很好,與其擔心股價波動,“我擔心的風險是永久性損失……所有我認識的務實投資者都這麼想。”因此,明智的投資者都知道,債務——通常與破產有關——是評估公司風險的重要因素。重要的是,Science Applications International Corporation(納斯達克:SAIC)確實負債。但股東們應該擔心它對債務的使用嗎?

Why Does Debt Bring Risk?

爲什麼債務會帶來風險?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

當企業無法便利地用自由現金流或以優惠價格籌集資金來滿足債務和其他負債時,債務和其他負債會變成企業的風險。最終,如果企業無法履行償還債務的法律義務,則股東可能一無所獲。然而,更頻繁(但仍然代價高昂)的情況是,公司必須以低於市場價的價格發行股票,永久稀釋股東權益,以改善其資產負債表。當然,債務可以成爲企業的重要工具,尤其是在資本密集型企業中。在考慮企業使用了多少債務時,首先要做的是將其現金和債務放在一起看。

How Much Debt Does Science Applications International Carry?

Science Applications International承載了多少的債務?

The image below, which you can click on for greater detail, shows that Science Applications International had debt of US$2.10b at the end of February 2024, a reduction from US$2.37b over a year. However, it also had US$94.0m in cash, and so its net debt is US$2.01b.

下圖顯示,截至2024年2月底,Science Applications International的債務爲21億美元,而去年同期爲23.7億美元。然而,它也持有9400萬美元的現金,所以其淨債務爲20.1億美元。

debt-equity-history-analysis
NasdaqGS:SAIC Debt to Equity History June 3rd 2024
納斯達克:SAIC債務與股權歷史

How Healthy Is Science Applications International's Balance Sheet?

Science Applications International的資產負債表狀況如何?

We can see from the most recent balance sheet that Science Applications International had liabilities of US$1.16b falling due within a year, and liabilities of US$2.37b due beyond that. Offsetting these obligations, it had cash of US$94.0m as well as receivables valued at US$914.0m due within 12 months. So its liabilities total US$2.52b more than the combination of its cash and short-term receivables.

我們可以從最新資產負債表看到,Science Applications International擁有11.6億美元的負債需要在一年內到期,23.7億美元的負債需要在一年以上到期。抵銷這些負債的是,它擁有9400萬美元的現金,以及12個月內到期的價值爲9.14億美元的應收賬款。所以,這些負債總計比它的現金和短期應收賬款的組合還要多25.2億美元。

Science Applications International has a market capitalization of US$6.90b, so it could very likely raise cash to ameliorate its balance sheet, if the need arose. But we definitely want to keep our eyes open to indications that its debt is bringing too much risk.

Science Applications International的市值爲69億美元,因此,如果需要,它可能非常有可能籌集資金來改善資產負債表。但我們絕對要注意其債務帶來過多風險的跡象。

We use two main ratios to inform us about debt levels relative to earnings. The first is net debt divided by earnings before interest, tax, depreciation, and amortization (EBITDA), while the second is how many times its earnings before interest and tax (EBIT) covers its interest expense (or its interest cover, for short). Thus we consider debt relative to earnings both with and without depreciation and amortization expenses.

我們使用兩個主要的比率來告訴我們相對於收益的債務水平。第一個是淨債務除以利息、稅、折舊和攤銷前利潤(EBITDA),而第二個是其利潤前利息和稅(EBIT)覆蓋其利息費用的次數(或其利息覆蓋率,簡稱)。因此,我們考慮與折舊和攤銷費用相關的盈利以及沒有相關費用的盈利相對於債務水平。

Science Applications International's debt is 3.0 times its EBITDA, and its EBIT cover its interest expense 4.4 times over. This suggests that while the debt levels are significant, we'd stop short of calling them problematic. Notably, Science Applications International's EBIT was pretty flat over the last year, which isn't ideal given the debt load. The balance sheet is clearly the area to focus on when you are analysing debt. But it is future earnings, more than anything, that will determine Science Applications International's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

Science Applications International的債務是其稅前利潤倍數的3.0倍,其稅前利潤也足以覆蓋其利息支付4.4倍。這表明儘管債務水平相當高,我們不敢將其稱爲有問題的程度。值得注意的是,過去一年,Science Applications International的稅前利潤基本保持不變,這對於其負債負擔並不理想。當你分析債務時,資產負債表顯然是重點關注的領域。但是未來收益,尤其是未來收益,將決定Science Applications International維持健康資產負債表的能力。因此,如果您想了解專業人士的想法,您可能會發現分析師盈利預測的這份免費報告有趣。

Finally, while the tax-man may adore accounting profits, lenders only accept cold hard cash. So the logical step is to look at the proportion of that EBIT that is matched by actual free cash flow. During the last three years, Science Applications International generated free cash flow amounting to a very robust 86% of its EBIT, more than we'd expect. That puts it in a very strong position to pay down debt.

最後,雖然稅務機關可能喜歡會計利潤,但貸款人只接受冰冷的現金。因此,邏輯上的下一步是查看與實際自由現金流相匹配的稅前利潤比例。在過去三年中,Science Applications International產生的自由現金流相當穩健,達到其稅前利潤的86%以上,超出了我們的預期。這讓它處於非常強勁的償還債務的位置。

Our View

我們的觀點

When it comes to the balance sheet, the standout positive for Science Applications International was the fact that it seems able to convert EBIT to free cash flow confidently. But the other factors we noted above weren't so encouraging. For example, its net debt to EBITDA makes us a little nervous about its debt. Considering this range of data points, we think Science Applications International is in a good position to manage its debt levels. But a word of caution: we think debt levels are high enough to justify ongoing monitoring. When analysing debt levels, the balance sheet is the obvious place to start. However, not all investment risk resides within the balance sheet - far from it. For example Science Applications International has 3 warning signs (and 2 which don't sit too well with us) we think you should know about.

在資產負債表方面,Science Applications International的顯着優勢是它似乎能夠自信地將稅前利潤轉換爲自由現金流。但是我們上面提到的其他因素並不太令人鼓舞。例如,它的淨債務與稅前利潤倍數讓我們對它的債務感到有些緊張。考慮到這些數據點,我們認爲Science Applications International處於良好的債務管理位置。但有一個警告:我們認爲債務水平已高到需要持續監測的程度。在分析債務水平時,資產負債表是明顯的起點。但不是所有的投資風險都屬於資產負債表——遠非如此。例如,Science Applications International有三個警告信號(和兩個對我們不是太好的信號),我們認爲您應該知道。

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

當然,如果您是那種喜歡購買沒有負債負擔的股票的投資者,則今天就可以發現我們的獨家淨現金增長股清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論